These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25819855)

  • 1. Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium.
    Sager PT; Seltzer J; Turner JR; Anderson JL; Hiatt WR; Kowey P; Prochaska JJ; Stockbridge N; White WB
    Am Heart J; 2015 Apr; 169(4):486-95. PubMed ID: 25819855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research Consortium.
    Seltzer JH; Turner JR; Geiger MJ; Rosano G; Mahaffey KW; White WB; Sabol MB; Stockbridge N; Sager PT
    Am Heart J; 2015 Feb; 169(2):197-204. PubMed ID: 25641528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tank.
    Seifert HA; Malik RE; Bhattacharya M; Campbell KR; Okun S; Pierce C; Terkowitz J; Turner JR; Krucoff MW; Powell GE
    Am Heart J; 2017 Dec; 194():107-115. PubMed ID: 29223428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular drug development: is it dead or just hibernating?
    Fordyce CB; Roe MT; Ahmad T; Libby P; Borer JS; Hiatt WR; Bristow MR; Packer M; Wasserman SM; Braunstein N; Pitt B; DeMets DL; Cooper-Arnold K; Armstrong PW; Berkowitz SD; Scott R; Prats J; Galis ZS; Stockbridge N; Peterson ED; Califf RM
    J Am Coll Cardiol; 2015 Apr; 65(15):1567-82. PubMed ID: 25881939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation therapy for hypertension: pathways for moving development forward.
    White WB; Galis ZS; Henegar J; Kandzari DE; Victor R; Sica D; Townsend RR; Turner JR; Virmani R; Mauri L
    J Am Soc Hypertens; 2015 May; 9(5):341-50. PubMed ID: 25979410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium.
    Piccini JP; Clark RL; Kowey PR; Mittal S; Dunnmon P; Stockbridge N; Reiffel JA; Turakhia MP; Ziegler PD; Kleiman RB; Ismat F; Sager P
    Am Heart J; 2017 May; 187():156-169. PubMed ID: 28454799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium.
    Sager P; Heilbraun J; Turner JR; Gintant G; Geiger MJ; Kowey PR; Mansoor GA; Mendzelevski B; Michelson EL; Stockbridge N; Weber MA; White WB
    Am Heart J; 2013 Apr; 165(4):477-88. PubMed ID: 23537963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the Drug Trials Snapshots Program of the US Food and Drug Administration: Women in Cardiovascular Drug Trials.
    Whyte J; Woodcock J; Wang J
    JAMA Intern Med; 2017 May; 177(5):724-727. PubMed ID: 28288256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of Older People Reflective of Real-World Clinical Practice in Cardiovascular Drug Trials.
    Caughey GE; Inacio MC; Bell JS; Vitry AI; Shakib S
    J Am Heart Assoc; 2020 Nov; 9(21):e016936. PubMed ID: 33103558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges.
    Heinonen TM; Aamer M; Marshall C; Black DM; Tardif JC
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):989-94. PubMed ID: 23030288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find?
    Downey M; Still C; Sharma AM
    Curr Opin Endocrinol Diabetes Obes; 2011 Oct; 18(5):321-7. PubMed ID: 21878755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an action plan for patient radiation safety in adult cardiovascular medicine: proceedings from the Duke University Clinical Research Institute/American College of Cardiology Foundation/American Heart Association think tank held on February 28, 2011.
    Douglas PS; Carr JJ; Cerqueira MD; Cummings JE; Gerber TC; Mukherjee D; Taylor AJ
    Circ Cardiovasc Imaging; 2012 May; 5(3):400-14. PubMed ID: 22441696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric cardiovascular safety: challenges in drug and device development and clinical application.
    Bates KE; Vetter VL; Li JS; Cummins S; Aguel F; Almond C; Dubin AM; Elia J; Finkle J; Hausner EA; Joseph F; Karkowsky AM; Killeen M; Lemacks J; Mathis L; McMahon AW; Pinnow E; Rodriguez I; Stockbridge NL; Stockwell M; Tassinari M; Krucoff MW
    Am Heart J; 2012 Oct; 164(4):481-92. PubMed ID: 23067905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
    Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
    Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration.
    Newby LK; Rodriguez I; Finkle J; Becker RC; Hicks KA; Hausner E; Chesler R; Harper C; Targum S; Berridge BR; Lewis E; Walker DB; Dollery C; Turner JR; Krucoff MW
    Am Heart J; 2011 Jul; 162(1):64-73. PubMed ID: 21742091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank.
    Al-Khatib SM; Calkins H; Eloff BC; Kowey P; Hammill SC; Ellenbogen KA; Marinac-Dabic D; Waldo AL; Brindis RG; Wilbur DJ; Jackman WM; Yaross MS; Russo AM; Prystowsky E; Varosy PD; Gross T; Pinnow E; Turakhia MP; Krucoff MW
    Am Heart J; 2010 Oct; 160(4):619-26. PubMed ID: 20934554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank.
    Al-Khatib SM; Calkins H; Eloff BC; Packer DL; Ellenbogen KA; Hammill SC; Natale A; Page RL; Prystowsky E; Jackman WM; Stevenson WG; Waldo AL; Wilber D; Kowey P; Yaross MS; Mark DB; Reiffel J; Finkle JK; Marinac-Dabic D; Pinnow E; Sager P; Sedrakyan A; Canos D; Gross T; Berliner E; Krucoff MW
    Am Heart J; 2010 Jan; 159(1):17-24. PubMed ID: 20102862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the cardiovascular safety of diabetes therapies.
    Goldfine AB
    N Engl J Med; 2008 Sep; 359(11):1092-5. PubMed ID: 18784098
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
    Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F
    Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety in clinical trials in cardiovascular disease.
    Cohn JN
    J Am Coll Cardiol; 2006 Aug; 48(3):430-3. PubMed ID: 16875964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.